Monoclonal Antibody Drops Fat, Ups Muscle in Obesity, Diabetes
'Blockade of the activin receptor with bimagrumab could provide a novel pharmacologic approach for managing patients with type 2 diabetes with excess adiposity,' researchers report. Medscape Medical News